Project REAL FIB: atrial fibrillation in real Praxis register

ISRCTN ISRCTN33778999
DOI https://doi.org/10.1186/ISRCTN33778999
Secondary identifying numbers 2009, protocol version 6.0, 18.01.2010
Submission date
09/03/2010
Registration date
06/04/2010
Last edited
06/04/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Robert Hatala
Scientific

Národný ústav srdcových a cievnych chorôb
Pod Krásnou hôrkou 1
Bratislava 37
833 48
Slovakia

Email hatala@nusch.sk

Study information

Study designMulticentre non-interventional observational prospective cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Other
Study typeDiagnostic
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleProject REAL FIB - atrial fibrillation in real Praxis register: a multicentre, non-interventional, observational and prospective study
Study acronymREAL FIB
Study objectivesCharting of therapeutic methods indicated by medical doctors of different specialisations (cardiologists, internists) in prevention of atrial fibrillation from all over the country.
Ethics approval(s)Multicentric Ethics Committee approved on the 21st December 2009 (ref: 108728/2009-11)
Health condition(s) or problem(s) studiedAtrial fibrillation (AF)
InterventionThis is a non-interventional study, all interventions will be performed according to common clinical Praxis in the management and follow up of patients with atrial fibrillation on treatment.

Baseline visit:
1. Demographic data collection
2. Risk factors assessment: height, weight, age, patient history (hypertension, age when AF diagnosed, coronary disease, heart failure, New York Heart Association [NYHA] classification, systolic dysfunction, ejection fraction, diastolic dysfunction, sick sinus syndrome, cardiostimulator, implantable cardioverter-defibrillator [ICD], history of cardiovascular surgery, other heart diseases, mitral valve disease and type, diabetes mellitus), blood sugar level, dyslipidaemia, cholesterol level, low density lipoprotein [LDL]-cholesterol level, chronic renal insufficiency, creatinine, urea, ions, thyreopathy, body mass index [BMI], transient ischaemic attack [TIA]/cerebrovascular accident [CVA], alcohol abuse, family history for AF, CHADS score
3. AF characteristics
4. Treatment strategy (rhythm control, frequency control, thrombembolism prevention, other treatment)

Follow up (6 months):
1. Basic data
2. Accidental events
3. Treatment strategy

Follow up (12 months):
1. Basic data
2. Accidental events
3. Treatment strategy
Intervention typeOther
Primary outcome measure1. To assess clinical profile of patients with atrial fibrillation
2. To assess contemporary treatment modalities and its effectiveness
3. To observe occurence of cardiovascular events prospectively
Secondary outcome measures1. To analyse correlation between treatment modalities indicated by medical doctors of different specialisations (cardiologists, internists) in prevention of atrial fibrillation
2. To collect treatment safety data
Overall study start date01/02/2010
Completion date30/04/2011

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participants1000
Key inclusion criteriaAll patients diagnosed with atrial fibrillation (any age, either sex)
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/02/2010
Date of final enrolment30/04/2011

Locations

Countries of recruitment

  • Slovakia

Study participating centre

Národný ústav srdcových a cievnych chorôb
Bratislava 37
833 48
Slovakia

Sponsor information

Masaryk University (Czech Republic)
University/education

c/o Doc. RNDr. Ladislav Dušek, Ph.D.
Institute of Biostatistics and Analyses
Faculty of Medicine and the Faculty of Science
Kamenice 2
Brno-Bohunice
625 00
Czech Republic

Email dusek@iba.muni.cz
Website http://www.muni.cz/
ROR logo "ROR" https://ror.org/02j46qs45

Funders

Funder type

University/education

Masaryk University (Czech Republic) - Institute of Biostatistics and Analyses at the Faculty of Medicine and the Faculty of Science

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan